Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT00550615 · COMPLETED
Trial details
- NCT number
- NCT00550615
- Sponsor
- University of Nebraska
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-17
- Primary completion
- 2016-08-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.